X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (118) 118
Publication (26) 26
Book Review (4) 4
Book / eBook (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (41) 41
index medicus (39) 39
middle aged (33) 33
aged (31) 31
female (31) 31
male (31) 31
hematology (29) 29
adult (26) 26
life sciences (22) 22
oncology (19) 19
bortezomib (15) 15
multiple myeloma (15) 15
survival (15) 15
aged, 80 and over (14) 14
cancer (14) 14
multiple myeloma - drug therapy (13) 13
prognosis (13) 13
treatment outcome (13) 13
abridged index medicus (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
lenalidomide (12) 12
dexamethasone (11) 11
disease-free survival (10) 10
chemotherapy (9) 9
multiple myeloma - mortality (9) 9
multiple myeloma - pathology (9) 9
survival analysis (9) 9
survival rate (9) 9
therapy (9) 9
[sdv.can]life sciences [q-bio]/cancer (8) 8
dexamethasone - administration & dosage (8) 8
prospective studies (8) 8
multiple myeloma - genetics (7) 7
transplantation (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
cyclophosphamide - administration & dosage (6) 6
disease (6) 6
elderly-patients (6) 6
melphalan - administration & dosage (6) 6
minimal residual disease (6) 6
stem-cell transplantation (6) 6
[sdv]life sciences [q-bio] (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
diagnosed multiple-myeloma (5) 5
doxorubicin - administration & dosage (5) 5
follow-up studies (5) 5
melphalan (5) 5
multiple myeloma - diagnosis (5) 5
neoplasm staging (5) 5
prednisone - administration & dosage (5) 5
remission induction (5) 5
thalidomide - administration & dosage (5) 5
translocation, genetic (5) 5
vincristine - administration & dosage (5) 5
[ sdv.can ] life sciences [q-bio]/cancer (4) 4
[ sdv.gen ] life sciences [q-bio]/genetics (4) 4
abnormalities (4) 4
adolescent (4) 4
bortezomib - administration & dosage (4) 4
chromosome deletion (4) 4
clinical trials (4) 4
cytogenetics (4) 4
diagnosis (4) 4
follow-up (4) 4
genetics (4) 4
induction (4) 4
multiple myeloma - therapy (4) 4
multiple-myeloma (4) 4
non-hodgkins-lymphoma (4) 4
patients (4) 4
salvage therapy (4) 4
thalidomide - adverse effects (4) 4
thalidomide - analogs & derivatives (4) 4
young adult (4) 4
102 (3) 3
[ sdv ] life sciences [q-bio] (3) 3
age factors (3) 3
antibodies, monoclonal - administration & dosage (3) 3
autografts (3) 3
autologous transplantation (3) 3
chromosomes, human, pair 14 - genetics (3) 3
chromosomes, human, pair 17 (3) 3
chromosomes, human, pair 4 (3) 3
chromosomes, human, pair 4 - genetics (3) 3
criteria (3) 3
dexamethasone - adverse effects (3) 3
dexamethasone - therapeutic use (3) 3
dosage and administration (3) 3
dose-response relationship, drug (3) 3
expression (3) 3
flow cytometry (3) 3
france (3) 3
hematopoietic stem cell transplantation (3) 3
hemic and lymphatic diseases (3) 3
heterogeneity (3) 3
immunoglobulin light chains - blood (3) 3
immunotherapy (3) 3
induction chemotherapy (3) 3
intergroupe francophone (3) 3
leukemia, myeloid, acute - mortality (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 14, pp. 1311 - 1320
In this trial, 700 patients with myeloma were randomly assigned to receive RVD therapy (lenalidomide, bortezomib, and dexamethasone) with or without autologous... 
DIAGNOSED MULTIPLE-MYELOMA | MEDICINE, GENERAL & INTERNAL | PHASE-III | AUTOLOGOUS TRANSPLANTATION | DARATUMUMAB MONOTHERAPY | INITIAL TREATMENT | FOLLOW-UP | PREDNISONE PLUS THALIDOMIDE | RANDOMIZED CONTROLLED-TRIAL | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Dexamethasone - adverse effects | Induction Chemotherapy | Male | Transplantation, Autologous | Stem Cell Transplantation | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Adult | Female | Maintenance Chemotherapy | Thalidomide - adverse effects | Dexamethasone - administration & dosage | Lenalidomide | Kaplan-Meier Estimate | Combined Modality Therapy | Thalidomide - administration & dosage | Disease-Free Survival | Bortezomib - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bortezomib - adverse effects | Aged | Usage | Care and treatment | Bortezomib | Dexamethasone | Patient outcomes | Multiple myeloma | Transplantation of organs, tissues, etc | Dosage and administration | Autografts | Gastrointestinal tract diseases | Minimal residual disease | Stem cell transplantation | Peripheral neuropathy | Patients | Chemotherapy | Melphalan | Thromboembolism | Neutropenia | Life Sciences | Cancer
Journal Article
Hematologie, ISSN 1264-7527, 05/2015, Volume 21, Issue 3, pp. 155 - 157
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2010, Volume 28, Issue 30, pp. 4630 - 4634
Journal Article
Journal Article
Journal Article
Hematologie, ISSN 1264-7527, 05/2015, Volume 21, Issue 3, pp. 153 - 155
Journal Article
The Lancet, ISSN 0140-6736, 07/2019, Volume 394, Issue 10192, pp. 29 - 38
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2019, Volume 187, Issue 3, pp. 319 - 327
Summary Single agent daratumumab has shown clinical activity in relapsed, refractory multiple myeloma (RRMM). The Intergroupe Francophone du Myélome 2014‐04... 
clinical trial | myeloma therapy | daratumumab | Dexamethasone | Multiple myeloma | Refractory materials | Infusion | Toxicity | Medical services | Toxic diseases | Survival | Patients
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2017, Volume 35, Issue 25, pp. 2911 - 2918
Journal Article
Blood, ISSN 0006-4971, 2013, Volume 121, Issue 11, pp. 1968 - 1975
The combination of pomalidomide and dexamethasone can be safely administered to patients with multiple myeloma (MM) and has significant efficacy, although the... 
SURVIVAL | MULTICENTER | THERAPY | EVENTS | RISK | COMBINATION | HEMATOLOGY | Index Medicus | Abridged Index Medicus | Life Sciences | Genetics
Journal Article
Blood, ISSN 0006-4971, 05/2016, Volume 127, Issue 21, pp. 2569 - 2574
Journal Article
by Pertesi, M and Vallee, M and Wei, XM and Revuelta, MV and Galia, P and Demangel, D and Oliver, J and Foll, M and Chen, S and Perrial, E and Garderet, L and Corre, J and Leleu, X and Boyle, EM and Decaux, O and Rodon, P and Kolb, B and Slama, B and Mineur, P and Voog, E and Le Bris, C and Fontan, J and Maigre, M and Beaumont, M and Azais, I and Sobol, H and Vignon, M and Royer, B and Perrot, A and Fuzibet, JG and Dorvaux, V and Anglaret, B and Cony-Makhoul, P and Berthou, C and Desquesnes, F and Pegourie, B and Leyvraz, S and Mosser, L and Frenkiel, N and Augeul-Meunier, K and Leduc, I and Leyronnas, C and Voillat, L and Casassus, P and Mathiot, C and Cheron, N and Paubelle, E and Moreau, P and Bignon, YJ and Joly, B and Bourquard, P and Caillot, D and Naman, H and Rigaudeau, S and Marit, G and Macro, M and Lambrecht, I and Cliquennois, M and Vincent, L and Helias, P and Avet-Loiseau, H and Moreno, V and Reis, RM and Varkonyi, J and Kruszewski, M and Vangsted, AJ and Jurczyszyn, A and Zaucha, JM and Sainz, J and Krawczyk-Kulis, M and Watek, M and Pelosini, M and Iskierka-Jazdzewska, E and Grzasko, N and Martinez-Lopez, J and Jerez, A and Campa, D and Buda, G and Lesueur, F and Dudzinski, M and Garcia-Sanz, R and Nagler, A and Rymko, M and Jamroziak, K and Butrym, A and Canzian, F and Obazee, O and Nilsson, B and Klein, RJ and Lipkin, SM and McKay, JD and Dumontet, C and Lund University and et al and Division of Hematology and Transfusion Medicine and BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation and Hematogenomics and Lunds universitet and Avdelningen för hematologi och transfusionsmedicin
LEUKEMIA, ISSN 0887-6924, 09/2019, Volume 33, Issue 9, pp. 2324 - 2330
Journal Article